Thromboxane metabolite excretion is associated with serious vascular events in diabetes mellitus: a sub-study of the ASCEND trial

類似資料

• Thromboxane biosynthesis and future events in diabetes: the ASCEND trial
  著者:: Petrucci, G, 等
  出版事項: (2024)
• Effect of low-dose aspirin on urinary 11-dehydro-thromboxane B2 in the ASCEND (A Study of Cardiovascular Events iN Diabetes) randomized controlled trial
  著者:: Parish, S, 等
  出版事項: (2023)
• Once daily low-dose aspirin reduces urinary thromboxane B2 effectively even at 12-24 hours from dosing in the ASCEND (A Study of Cardiovascular Events iN Diabetes) trial
  著者:: Aung, T, 等
  出版事項: (2017)
• Effect of low-dose aspirin on urinary 11-dehydro-thromboxane B2 in the ASCEND (A Study of Cardiovascular Events iN Diabetes) randomized controlled trial
  著者:: Sarah Parish, 等
  出版事項: (2023-03-01)
• Measurement of Thromboxane Biosynthesis in Health and Disease
  著者:: Carlo Patrono, 等
  出版事項: (2019-10-01)